Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
TEVA | Market Realist
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Seasonal Chart | Equity Clock
Teva Pharamceutical (NYSE:TEVA) Surges After Earnings Report - TipRanks.com
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Revenue Growth
Teva Pharmaceutical Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 -August 02, 2023 at 07:13 am EDT | MarketScreener
Teva, armed with 2 recent launches, raises revenue guidance
TEVA Plunges on Q1 Results - TipRanks.com
Teva CEO Richard Francis on Q2 earnings beat
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva's Copaxone Successors Are Still Far From Success | Ctech
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical Industries Ltd (ADR) Needs More Than Job Cuts
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook | AlphaStreet
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
TEVA: A Pharmaceutical Stock to Watch Right Now - See It Market
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical Industries (NYSE:TEVA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Teva earnings preview: Opioid suits are 'key' - MarketWatch
